Literature DB >> 29848704

Knockdown of 14-3-3γ Suppresses Epithelial-Mesenchymal Transition and Reduces Metastatic Potential of Human Non-small Cell Lung Cancer Cells.

Pritsana Raungrut1, Anusara Wongkotsila2, Nidanut Champoochana2, Kriengsak Lirdprapamongkol3, Jisnuson Svasti3, Paramee Thongsuksai4.   

Abstract

BACKGROUND/AIM: 14-3-3γ is involved in the metastasis of lung cancer cells. However, its functional roles in tumor cell invasion and the underlying mechanisms are still not understood. In this study, the roles and molecular mechanisms of 14-3-3γ in epithelial-mesenchymal transition (EMT), migration, and invasion were investigated using A549 and H358 non-small cell lung cancer (NSCLC) cell lines.
MATERIALS AND METHODS: siRNA against 14-3-3γ was used to suppress 14-3-3γ expression. Expression levels of proteins were detected by western blotting. Activity of matrix metalloproteinases (MMP)-2 and MMP9 was determined by gelatin zymography. Cell migration and invasion were analyzed using the Transwell assay.
RESULTS: Knockdown of 14-3-3γ resulted in a significant reduction of expression of EMT-associated proteins in NSCLC cell lines, and led to significant reduction in invasion and migration by approximately 59% and 39% in A549 cells, and 65% and 62% in H358 cells, respectively. In addition, MMP2 and MMP9 activity was significantly reduced in both NSCLC cell lines after down-regulation of 14-3-3γ.
CONCLUSION: Our results suggest that knockdown of 14-3-3γ may be a potential strategy for suppressing metastasis of lung cancer by inhibiting MMP2 and MMP9 through regulation of EMT. Copyright
© 2018, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  14-3-3γ; epithelial–mesenchymal transition; invasion; matrix metalloproteinases; migration; non-small cell lung cancer; siRNA

Mesh:

Substances:

Year:  2018        PMID: 29848704     DOI: 10.21873/anticanres.12622

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  8 in total

1.  Quantitative Analysis of Ubiquitinated Proteins in Human Pituitary and Pituitary Adenoma Tissues.

Authors:  Shehua Qian; Xiaohan Zhan; Miaolong Lu; Na Li; Ying Long; Xuejun Li; Dominic M Desiderio; Xianquan Zhan
Journal:  Front Endocrinol (Lausanne)       Date:  2019-05-22       Impact factor: 5.555

2.  GDPLichi: a DNA Damage Repair-Related Gene Classifier for Predicting Lung Adenocarcinoma Immune Checkpoint Inhibitors Response.

Authors:  Yang Leng; Shiying Dang; Fei Yin; Tianshun Gao; Xing Xiao; Yi Zhang; Lin Chen; Changfei Qin; Nannan Lai; Xiao-Yong Zhan; Ke Huang; Chuanming Luo; Yang Kang; Nan Wang; Yun Li; Yuhong Liang; Bihui Huang
Journal:  Front Oncol       Date:  2021-12-02       Impact factor: 6.244

3.  Quantitative Acetylomics Revealed Acetylation-Mediated Molecular Pathway Network Changes in Human Nonfunctional Pituitary Neuroendocrine Tumors.

Authors:  Siqi Wen; Jiajia Li; Jingru Yang; Biao Li; Na Li; Xianquan Zhan
Journal:  Front Endocrinol (Lausanne)       Date:  2021-10-12       Impact factor: 5.555

4.  Investigation and Functional Enrichment Analysis of the Human Host Interaction Network with Common Gram-Negative Respiratory Pathogens Predicts Possible Association with Lung Adenocarcinoma.

Authors:  Lydia-Eirini Giannakou; Athanasios-Stefanos Giannopoulos; Chrissi Hatzoglou; Konstantinos I Gourgoulianis; Erasmia Rouka; Sotirios G Zarogiannis
Journal:  Pathophysiology       Date:  2021-01-02

5.  Curcumenol Targeting YWHAG Inhibits the Pentose Phosphate Pathway and Enhances Antitumor Effects of Cisplatin.

Authors:  Zhijie Mao; Liyan Zhong; Xiaodan Zhuang; Haoen Liu; Yan Peng
Journal:  Evid Based Complement Alternat Med       Date:  2022-06-26       Impact factor: 2.650

Review 6.  Role of Deubiquitinases in Human Cancers: Potential Targeted Therapy.

Authors:  Keng Po Lai; Jian Chen; William Ka Fai Tse
Journal:  Int J Mol Sci       Date:  2020-04-06       Impact factor: 5.923

7.  Identification of dissociation factors in pancreatic Cancer using a mass spectrometry-based proteomic approach.

Authors:  Peng Liu; Lingming Kong; Keke Liang; Yunhao Wu; Haoyi Jin; Bing Song; Xiaodong Tan
Journal:  BMC Cancer       Date:  2020-01-20       Impact factor: 4.430

8.  Triptolide suppresses the growth and metastasis of non-small cell lung cancer by inhibiting β-catenin-mediated epithelial-mesenchymal transition.

Authors:  Qiu-di Deng; Xue-Ping Lei; Yi-Hang Zhong; Min-Shan Chen; Yuan-Yu Ke; Zhan Li; Jing Chen; Li-Juan Huang; Yu Zhang; Lu Liang; Zhong-Xiao Lin; Qing Liu; Song-Pei Li; Xi-Yong Yu
Journal:  Acta Pharmacol Sin       Date:  2021-04-23       Impact factor: 6.150

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.